OXYCODONE

OXYCODONE was reported 217261 times

OXYCODONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 93 0.6242
1 C-REACTIVE PROTEIN 543 0.5858
2 FACET JOINT SYNDROME 1737 0.5330
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 1021 0.5097
4 DUODENAL ULCER PERFORATION 3660 0.4917
5 RHEUMATIC FEVER 2068 0.4635
6 MUSCLE INJURY 3802 0.4584
7 SWOLLEN JOINT COUNT INCREASED 1420 0.4449
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3160 0.4406
9 LUPUS VULGARIS 538 0.4270
10 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 275 0.4117
11 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2675 0.4115
12 FOLLICULITIS 4314 0.4110
13 RED BLOOD CELL SEDIMENTATION RATE 114 0.4086
14 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 227 0.4046
15 HYPOCHOLESTEROLAEMIA 136 0.3853
16 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 798 0.3848
17 SWOLLEN JOINT COUNT 96 0.3840
18 DRUG DIVERSION 2300 0.3720
19 HELICOBACTER INFECTION 3658 0.3556
20 DISLOCATION OF VERTEBRA 783 0.3430
21 PERIPHERAL VENOUS DISEASE 1321 0.3231
22 X-RAY ABNORMAL 560 0.3128
23 PEMPHIGUS 3815 0.3048
24 C-REACTIVE PROTEIN ABNORMAL 1856 0.2891
25 RHEUMATOID FACTOR POSITIVE 1637 0.2831
26 HAND DEFORMITY 3659 0.2787
27 RETINITIS 478 0.2765
28 VICTIM OF HOMICIDE 133 0.2285
29 PERICARDITIS 3731 0.2218
30 SYNOVITIS 3958 0.2193
31 BREAST CANCER STAGE III 1327 0.2047
32 IRRITABLE BOWEL SYNDROME 4295 0.2001
33 LIP DRY 1785 0.1963
34 STEROID DEPENDENCE 154 0.1754
35 GLOSSODYNIA 3921 0.1750
36 CATARRH 157 0.1737
37 DRUG DEPENDENCE 27743 0.1724
38 TOXIC LEUKOENCEPHALOPATHY 125 0.1722
39 ONYCHOMADESIS 715 0.1702
40 BURSITIS 2004 0.1650
41 COUNTERFEIT PRODUCT ADMINISTERED 215 0.1649
42 OVERLAP SYNDROME 115 0.1643
43 OPISTHOTONUS 130 0.1635
44 JOINT RANGE OF MOTION DECREASED 2176 0.1621
45 WOUND INFECTION 1747 0.1594
46 SERONEGATIVE ARTHRITIS 182 0.1588
47 GRANULOMA SKIN 130 0.1583
48 PRODUCT COUNTERFEIT 271 0.1569
49 PORPHYRIA ACUTE 223 0.1554
50 ENTHESOPATHY 243 0.1553
51 LIVE BIRTH 1278 0.1526
52 BLEPHAROSPASM 918 0.1456
53 HYPERCHOLESTEROLAEMIA 1353 0.1400
54 WOUND 3889 0.1390
55 SUBSTANCE DEPENDENCE 92 0.1367
56 GRIP STRENGTH DECREASED 1189 0.1350
57 IMPAIRED HEALING 4391 0.1336
58 EMOTIONAL DISTRESS 15687 0.1294
59 BONE EROSION 456 0.1288
60 DRUG WITHDRAWAL SYNDROME NEONATAL 1813 0.1223
61 DRUG WITHDRAWAL SYNDROME 10545 0.1200
62 FIBROMYALGIA 2840 0.1167
63 SYSTEMIC LUPUS ERYTHEMATOSUS 4107 0.1156
64 LEARNING DISABILITY 614 0.1152
65 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 121 0.1139
66 AUTOIMMUNE DISORDER 1102 0.1129
67 ONYCHOMYCOSIS 493 0.1122
68 CONTRAINDICATED PRODUCT ADMINISTERED 3372 0.1113
69 HOMICIDE 199 0.1079
70 NAIL DISORDER 921 0.1052
71 MATERNAL EXPOSURE TIMING UNSPECIFIED 395 0.1051
72 FINGER DEFORMITY 508 0.1048
73 BLOOD PARATHYROID HORMONE DECREASED 151 0.1018
74 DRUG TOLERANCE DECREASED 284 0.1010
75 TOXICITY TO VARIOUS AGENTS 16586 0.0983
76 TENOSYNOVITIS 270 0.0978
77 BURNS SECOND DEGREE 171 0.0974
78 LOWER RESPIRATORY TRACT INFECTION 4417 0.0970
79 DRUG TOLERANCE 476 0.0940
80 SUBSTANCE USE DISORDER 294 0.0922
81 OVERDOSE 19314 0.0894
82 INFUSION SITE REACTION 267 0.0893
83 DRUG ABUSE 7395 0.0887
84 BACK INJURY 955 0.0877
85 LIVER INJURY 2139 0.0871
86 OBESITY 1372 0.0860
87 NEPHROGENIC ANAEMIA 383 0.0826
88 STOMATITIS 4922 0.0811
89 SCIATICA 1293 0.0810
90 PRODUCT LABEL CONFUSION 471 0.0807
91 HYPERPARATHYROIDISM SECONDARY 201 0.0801
92 ACCIDENTAL DEATH 149 0.0801
93 TYPE 2 DIABETES MELLITUS 2675 0.0794
94 BLISTER 4446 0.0791
95 DRUG USE DISORDER 641 0.0762
96 THERAPEUTIC PRODUCT EFFECT DECREASED 3393 0.0757
97 PRESCRIBED OVERDOSE 1447 0.0747
98 ALANINE AMINOTRANSFERASE ABNORMAL 155 0.0734
99 LOWER LIMB FRACTURE 1409 0.0733
100 ARTHROPATHY 4062 0.0730
101 RED BLOOD CELL SEDIMENTATION RATE INCREASED 804 0.0726
102 PSORIATIC ARTHROPATHY 2924 0.0720
103 PUSTULAR PSORIASIS 244 0.0710
104 SUBSTANCE ABUSE 578 0.0709
105 CANCER PAIN 181 0.0707
106 DEVELOPMENTAL DELAY 638 0.0707
107 TEMPERATURE REGULATION DISORDER 157 0.0704
108 NIGHT SWEATS 2214 0.0686
109 INFUSION RELATED REACTION 4430 0.0668
110 PANNICULITIS 161 0.0665
111 EXPOSURE VIA INGESTION 167 0.0661
112 GAIT INABILITY 2207 0.0660
113 BREAST CANCER STAGE II 548 0.0658
114 EXOSTOSIS 597 0.0653
115 HYPOPNOEA 222 0.0639
116 RHEUMATOID NODULE 175 0.0635
117 WALKING AID USER 411 0.0623
118 HEPATIC ENZYME INCREASED 4232 0.0620
119 BRADYPNOEA 164 0.0607
120 COELIAC DISEASE 596 0.0607
121 PULMONARY FIBROSIS 1157 0.0603
122 REBOUND ACID HYPERSECRETION 180 0.0594
123 ILL-DEFINED DISORDER 3573 0.0588
124 OSTEOARTHRITIS 2489 0.0587
125 RASH VESICULAR 280 0.0579
126 TASTE DISORDER 1126 0.0554
127 FEMALE GENITAL TRACT FISTULA 94 0.0550
128 ULCER HAEMORRHAGE 368 0.0543
129 DISCOMFORT 3303 0.0541
130 CONGENITAL ANOMALY 419 0.0541
131 SUSPECTED SUICIDE 252 0.0537
132 RESPIRATORY DEPRESSION 656 0.0535
133 ALCOHOL POISONING 143 0.0533
134 INADEQUATE ANALGESIA 452 0.0532
135 SWELLING 4921 0.0525
136 DELIRIUM 1818 0.0523
137 INJURY 3665 0.0521
138 BLOOD CHOLESTEROL INCREASED 2377 0.0509
139 LUPUS-LIKE SYNDROME 456 0.0502
140 ROAD TRAFFIC ACCIDENT 2038 0.0487
141 JOINT SWELLING 5797 0.0480
142 HIP ARTHROPLASTY 733 0.0478
143 HYPERAESTHESIA 393 0.0478
144 LIVER FUNCTION TEST INCREASED 1022 0.0476
145 EAR PAIN 923 0.0474
146 JOINT DISLOCATION 500 0.0473
147 WHEEZING 2740 0.0462
148 MATERNAL EXPOSURE DURING PREGNANCY 4105 0.0460
149 MIOSIS 366 0.0456
150 MUSCLE SPASTICITY 560 0.0455
151 DRUG INTOLERANCE 4385 0.0453
152 PRESCRIBED UNDERDOSE 901 0.0451
153 GASTROINTESTINAL DISORDER 4017 0.0448
154 COMPLETED SUICIDE 3717 0.0446
155 POST-TRAUMATIC STRESS DISORDER 297 0.0443
156 PAIN 27148 0.0442
157 SINUSITIS 4460 0.0435
158 C-REACTIVE PROTEIN INCREASED 1577 0.0433
159 BREAKTHROUGH PAIN 100 0.0432
160 ACCIDENTAL OVERDOSE 1577 0.0431
161 DRUG SCREEN POSITIVE 338 0.0427
162 END STAGE RENAL DISEASE 776 0.0425
163 SPINAL FUSION SURGERY 171 0.0421
164 RESPIRATORY ARREST 1155 0.0419
165 INFLAMMATION 2161 0.0418
166 MUSCULOSKELETAL PAIN 2179 0.0415
167 RHEUMATOID ARTHRITIS 4708 0.0414
168 SLEEP DISORDER 2916 0.0413
169 SPONDYLITIS 149 0.0409
170 MOBILITY DECREASED 2940 0.0409
171 NORMAL NEWBORN 218 0.0401
172 LUNG DISORDER 1959 0.0399
173 CONFUSIONAL STATE 6426 0.0397
174 POISONING 496 0.0394
175 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 675 0.0393
176 PERIPHERAL SWELLING 6054 0.0393
177 EYE INJURY 119 0.0391
178 KNEE ARTHROPLASTY 805 0.0382
179 DISABILITY 750 0.0379
180 RESPIRATORY RATE DECREASED 119 0.0378
181 INTENTIONAL PRODUCT USE ISSUE 3241 0.0370
182 BLOOD PRESSURE DIASTOLIC ABNORMAL 94 0.0369
183 OEDEMA 1998 0.0368
184 COMPARTMENT SYNDROME 96 0.0368
185 CONTUSION 3524 0.0366
186 FOOT DEFORMITY 398 0.0359
187 IMPAIRED QUALITY OF LIFE 516 0.0359
188 DRY MOUTH 2876 0.0354
189 RESPIRATORY ACIDOSIS 138 0.0351
190 TONGUE DISORDER 254 0.0351
191 CARDIO-RESPIRATORY ARREST 1463 0.0350
192 GENERAL PHYSICAL HEALTH DETERIORATION 4022 0.0347
193 GINGIVAL PAIN 274 0.0344
194 HEPATIC CIRRHOSIS 643 0.0342
195 BACK DISORDER 556 0.0342
196 EPILEPSY 1045 0.0342
197 DEAFNESS NEUROSENSORY 112 0.0340
198 SKIN NECROSIS 176 0.0339
199 BONE LESION 122 0.0338
200 PULSELESS ELECTRICAL ACTIVITY 141 0.0337
201 ADVERSE REACTION 445 0.0335
202 MYOSITIS 300 0.0334
203 LIVER DISORDER 1468 0.0331
204 APPARENT DEATH 119 0.0330
205 INFECTION 4780 0.0330
206 INTERVERTEBRAL DISC DEGENERATION 305 0.0329
207 PREGNANCY 660 0.0329
208 LUMBAR SPINAL STENOSIS 94 0.0321
209 MUSCULOSKELETAL STIFFNESS 2777 0.0317
210 METABOLIC ENCEPHALOPATHY 95 0.0316
211 ABDOMINAL DISCOMFORT 5277 0.0314
212 SEROTONIN SYNDROME 599 0.0312
213 THERAPY NON-RESPONDER 1387 0.0308
214 IMPAIRED WORK ABILITY 649 0.0303
215 CHRONIC KIDNEY DISEASE 2303 0.0303
216 BODY TEMPERATURE INCREASED 617 0.0302
217 TREATMENT FAILURE 2500 0.0301
218 ARTERIOSCLEROSIS CORONARY ARTERY 199 0.0300
219 BRAIN INJURY 299 0.0298
220 SPINAL OSTEOARTHRITIS 261 0.0297
221 FOETAL DEATH 154 0.0297
222 GENERAL SYMPTOM 221 0.0295
223 UNRESPONSIVE TO STIMULI 760 0.0294
224 BRONCHIECTASIS 198 0.0294
225 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1406 0.0292
226 IMPAIRED DRIVING ABILITY 330 0.0290
227 WITHDRAWAL SYNDROME 1206 0.0287
228 FAILURE TO THRIVE 149 0.0287
229 PRE-EXISTING CONDITION IMPROVED 179 0.0286
230 NASOPHARYNGITIS 5205 0.0282
231 HYPERCALCAEMIA 342 0.0277
232 RESPIRATORY DISORDER 826 0.0276
233 PAROSMIA 208 0.0275
234 MENTAL DISORDER 1195 0.0274
235 FUNCTIONAL GASTROINTESTINAL DISORDER 93 0.0269
236 TERMINAL STATE 179 0.0267
237 DENTAL CARIES 295 0.0266
238 WEIGHT INCREASED 5892 0.0263
239 RHINITIS 211 0.0261
240 CARDIAC MURMUR 226 0.0261
241 EXPOSURE DURING PREGNANCY 1621 0.0261
242 OSTEOPOROSIS 1071 0.0260
243 HYPERSENSITIVITY 4824 0.0260
244 GASTROOESOPHAGEAL REFLUX DISEASE 2087 0.0259
245 AMNESIA 1684 0.0259
246 DECUBITUS ULCER 210 0.0257
247 DRUG-INDUCED LIVER INJURY 806 0.0257
248 CHRONIC SINUSITIS 96 0.0256
249 SICKLE CELL ANAEMIA WITH CRISIS 401 0.0254
250 MIGRAINE 2417 0.0253
251 NECK PAIN 1407 0.0252
252 TUBULOINTERSTITIAL NEPHRITIS 471 0.0251
253 HYPOAESTHESIA 3757 0.0251
254 COMPRESSION FRACTURE 134 0.0250
255 ATELECTASIS 241 0.0249
256 DIVERTICULUM 177 0.0249
257 HOSPICE CARE 246 0.0249
258 HUMERUS FRACTURE 120 0.0249
259 MYOCLONUS 295 0.0247
260 ALOPECIA 4809 0.0245
261 DEPENDENCE 1340 0.0244
262 INTERVERTEBRAL DISC DISORDER 103 0.0241
263 JOINT STIFFNESS 630 0.0240
264 SPINAL STENOSIS 98 0.0237
265 PATHOLOGICAL FRACTURE 120 0.0236
266 DYSPEPSIA 2326 0.0236
267 SPINAL OPERATION 291 0.0236
268 MEDICATION ERROR 1311 0.0236
269 SMALL INTESTINAL OBSTRUCTION 289 0.0235
270 SLEEP APNOEA SYNDROME 448 0.0235
271 HEPATITIS 600 0.0234
272 FOOD ALLERGY 180 0.0233
273 MENTAL STATUS CHANGES 647 0.0233
274 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 143 0.0231
275 DEATH 19946 0.0231
276 SCOLIOSIS 143 0.0231
277 SPINAL COLUMN STENOSIS 109 0.0231
278 SUSPECTED OFF LABEL USE 104 0.0230
279 BEHAVIOUR DISORDER 124 0.0229
280 SEDATION 595 0.0227
281 ULCER 359 0.0225
282 SKIN ULCER 579 0.0224
283 DEPRESSION 5070 0.0223
284 URTICARIA 3727 0.0222
285 PSYCHOLOGICAL TRAUMA 190 0.0220
286 IMPAIRED GASTRIC EMPTYING 300 0.0220
287 QUALITY OF LIFE DECREASED 294 0.0219
288 VASCULAR DEVICE INFECTION 98 0.0216
289 FREQUENT BOWEL MOVEMENTS 583 0.0216
290 HEPATITIS C 260 0.0215
291 DECREASED APPETITE 4968 0.0214
292 PULMONARY THROMBOSIS 233 0.0213
293 INTERVERTEBRAL DISC PROTRUSION 466 0.0213
294 POISONING DELIBERATE 202 0.0213
295 MEMORY IMPAIRMENT 2917 0.0212
296 EUPHORIC MOOD 216 0.0211
297 HYPOXIA 738 0.0209
298 ACUTE KIDNEY INJURY 3205 0.0209
299 TRICUSPID VALVE INCOMPETENCE 166 0.0209
300 ABDOMINAL PAIN UPPER 4275 0.0207
301 OSTEOPENIA 314 0.0207
302 WEIGHT FLUCTUATION 216 0.0206
303 NERVE INJURY 229 0.0206
304 RIB FRACTURE 423 0.0205
305 ASPIRATION 225 0.0205
306 INTENTIONAL PRODUCT MISUSE 1793 0.0205
307 HYPERTENSION 4287 0.0202
308 PNEUMONIA ASPIRATION 504 0.0202
309 DEPRESSED LEVEL OF CONSCIOUSNESS 782 0.0197
310 CONSTIPATION 4294 0.0197
311 PYREXIA 6792 0.0196
312 ANXIETY 5580 0.0196
313 METASTASES TO BONE 320 0.0195
314 CARDIAC ARREST 1607 0.0194
315 FLANK PAIN 182 0.0194
316 PLASMA CELL MYELOMA 756 0.0194
317 TENDONITIS 300 0.0194
318 MUSCULAR WEAKNESS 2195 0.0193
319 ADRENAL INSUFFICIENCY 234 0.0193
320 IMMUNODEFICIENCY 287 0.0192
321 OSTEOMYELITIS 348 0.0192
322 SPINAL PAIN 224 0.0191
323 SPINAL DISORDER 181 0.0191
324 SPINAL COMPRESSION FRACTURE 158 0.0191
325 JOINT EFFUSION 131 0.0190
326 JOINT INJURY 404 0.0189
327 TENDERNESS 197 0.0189
328 BLOOD MAGNESIUM DECREASED 163 0.0189
329 CACHEXIA 97 0.0188
330 INSOMNIA 5021 0.0188
331 UPPER RESPIRATORY TRACT INFECTION 870 0.0188
332 MUSCULOSKELETAL CHEST PAIN 291 0.0188
333 NEURALGIA 454 0.0187
334 LYMPHOEDEMA 129 0.0186
335 FAECALOMA 102 0.0186
336 ARTHRALGIA 7684 0.0185
337 EAR INFECTION 490 0.0184
338 ORAL PAIN 411 0.0183
339 PROCTALGIA 118 0.0183
340 PRODUCT ADMINISTRATION INTERRUPTED 144 0.0183
341 ACUTE RESPIRATORY FAILURE 352 0.0183
342 DECREASED INTEREST 107 0.0181
343 TOOTH LOSS 376 0.0181
344 SPINAL FRACTURE 363 0.0181
345 HYPOVOLAEMIA 106 0.0181
346 MALNUTRITION 202 0.0180
347 RASH 7855 0.0180
348 FLUID RETENTION 912 0.0179
349 FULL BLOOD COUNT DECREASED 361 0.0179
350 VITAMIN D DECREASED 153 0.0179
351 STRESS CARDIOMYOPATHY 104 0.0179
352 BLOOD PRESSURE SYSTOLIC INCREASED 348 0.0178
353 RENAL TUBULAR NECROSIS 175 0.0178
354 RENAL INJURY 529 0.0178
355 ENCEPHALOPATHY 437 0.0178
356 DEEP VEIN THROMBOSIS 1156 0.0178
357 BRAIN OEDEMA 223 0.0176
358 ANHEDONIA 463 0.0176
359 ROTATOR CUFF SYNDROME 225 0.0175
360 BASAL CELL CARCINOMA 273 0.0175
361 HYSTERECTOMY 151 0.0174
362 OEDEMA PERIPHERAL 2114 0.0173
363 MUSCLE SPASMS 3166 0.0172
364 ANAL INCONTINENCE 155 0.0172
365 BODY HEIGHT DECREASED 184 0.0172
366 VOMITING 8082 0.0172
367 PNEUMONIA 5517 0.0170
368 POST PROCEDURAL INFECTION 138 0.0170
369 ECONOMIC PROBLEM 256 0.0169
370 LEUKOCYTOSIS 305 0.0168
371 EMPHYSEMA 170 0.0168
372 NERVE COMPRESSION 155 0.0168
373 HAIR COLOUR CHANGES 208 0.0167
374 ILEUS 207 0.0166
375 RECTAL HAEMORRHAGE 715 0.0166
376 BONE DISORDER 303 0.0166
377 HIATUS HERNIA 215 0.0166
378 BACK PAIN 3848 0.0165
379 RENAL FAILURE 2194 0.0165
380 CHEST PAIN 3044 0.0164
381 MAJOR DEPRESSION 120 0.0164
382 CONCUSSION 127 0.0164
383 HYPOKALAEMIA 753 0.0163
384 FATIGUE 12622 0.0162
385 CARDIOMEGALY 199 0.0162
386 CELLULITIS 815 0.0162
387 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1148 0.0161
388 FEEDING DISORDER 327 0.0161
389 HYPOPHAGIA 410 0.0160
390 FEAR OF INJECTION 114 0.0160
391 TOOTH FRACTURE 176 0.0159
392 THERMAL BURN 113 0.0159
393 TOOTH DISORDER 354 0.0159
394 SOMNOLENCE 3205 0.0159
395 ASTHMA 1796 0.0159
396 ARTHRITIS 1248 0.0158
397 ADVERSE EVENT 1462 0.0158
398 FOETAL EXPOSURE DURING PREGNANCY 1286 0.0158
399 CANDIDA INFECTION 267 0.0158
400 HAND FRACTURE 112 0.0158
401 PRODUCT PRESCRIBING ISSUE 344 0.0158
402 FOOT FRACTURE 298 0.0157
403 ACIDOSIS 120 0.0157
404 CLOSTRIDIUM DIFFICILE COLITIS 166 0.0156
405 COMA 743 0.0156
406 WEIGHT DECREASED 4353 0.0156
407 LOCALISED INFECTION 375 0.0155
408 IRON DEFICIENCY ANAEMIA 143 0.0155
409 PULMONARY CONGESTION 204 0.0155
410 BEDRIDDEN 203 0.0154
411 ASTHENIA 5801 0.0154
412 PARAESTHESIA 2427 0.0154
413 PULMONARY EMBOLISM 1466 0.0154
414 HAIR DISORDER 127 0.0154
415 PAIN IN EXTREMITY 4537 0.0154
416 PRURITUS 5911 0.0154
417 RESTLESS LEGS SYNDROME 279 0.0153
418 BONE PAIN 898 0.0153
419 CONDITION AGGRAVATED 4660 0.0153
420 NIGHTMARE 528 0.0152
421 URINARY RETENTION 509 0.0152
422 INTENTIONAL DRUG MISUSE 318 0.0152
423 LIGAMENT SPRAIN 150 0.0152
424 ADVERSE DRUG REACTION 1357 0.0151
425 METABOLIC ACIDOSIS 483 0.0151
426 SOMNAMBULISM 99 0.0151
427 BACTERAEMIA 179 0.0151
428 RENAL CYST 119 0.0150
429 NEUROPATHY PERIPHERAL 1424 0.0150
430 HYPERTRANSAMINASAEMIA 104 0.0149
431 ASCITES 439 0.0149
432 TOOTH ABSCESS 152 0.0149
433 ANKLE FRACTURE 231 0.0149
434 DIVERTICULITIS 413 0.0149
435 ABDOMINAL PAIN 3455 0.0148
436 PNEUMOTHORAX 235 0.0148
437 PRODUCT USE ISSUE 2784 0.0148
438 SEPSIS 1649 0.0148
439 HYPOPHOSPHATAEMIA 109 0.0147
440 ORAL DISORDER 108 0.0147
441 PULMONARY MASS 219 0.0147
442 HYDRONEPHROSIS 110 0.0147
443 ARTERIOSCLEROSIS 138 0.0146
444 MALIGNANT NEOPLASM PROGRESSION 1496 0.0146
445 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 248 0.0146
446 INCONTINENCE 154 0.0146
447 HYPERHIDROSIS 1875 0.0145
448 DYSPNOEA 8227 0.0145
449 BLOOD ALBUMIN DECREASED 115 0.0145
450 CEREBRAL DISORDER 107 0.0144
451 GAIT DISTURBANCE 2766 0.0144
452 TOOTHACHE 261 0.0144
453 SENSORY LOSS 116 0.0144
454 HYPERSOMNIA 412 0.0144
455 NAUSEA 11365 0.0143
456 KNEE OPERATION 141 0.0143
457 SINUS TACHYCARDIA 203 0.0143
458 LARGE INTESTINE PERFORATION 99 0.0142
459 BLOOD CALCIUM DECREASED 160 0.0142
460 BLOOD PRESSURE FLUCTUATION 341 0.0142
461 RED BLOOD CELL COUNT DECREASED 403 0.0141
462 FORMICATION 98 0.0141
463 BIPOLAR DISORDER 153 0.0141
464 FACIAL PAIN 125 0.0140
465 SPLENOMEGALY 164 0.0140
466 BOWEL MOVEMENT IRREGULARITY 107 0.0140
467 METASTASES TO LIVER 245 0.0139
468 LETHARGY 801 0.0139
469 ABDOMINAL DISTENSION 1450 0.0139
470 FALL 4604 0.0138
471 BLOOD PRESSURE DIASTOLIC DECREASED 102 0.0138
472 TOOTH INFECTION 182 0.0138
473 FEBRILE NEUTROPENIA 915 0.0138
474 PELVIC FRACTURE 107 0.0137
475 LIMB INJURY 371 0.0136
476 DIARRHOEA 8794 0.0136
477 POSTOPERATIVE WOUND INFECTION 92 0.0136
478 AFFECTIVE DISORDER 107 0.0136
479 DRUG TOXICITY 185 0.0136
480 UNEVALUABLE EVENT 1019 0.0135
481 UROSEPSIS 124 0.0134
482 WRIST FRACTURE 161 0.0134
483 NEOPLASM 154 0.0134
484 ANKYLOSING SPONDYLITIS 176 0.0133
485 CLOSTRIDIUM DIFFICILE INFECTION 291 0.0133
486 LARGE INTESTINE POLYP 92 0.0133
487 RIGHT VENTRICULAR FAILURE 93 0.0133
488 BLOOD POTASSIUM DECREASED 399 0.0133
489 LUNG INFILTRATION 117 0.0132
490 ACUTE RESPIRATORY DISTRESS SYNDROME 234 0.0132
491 APNOEA 103 0.0132
492 DEHYDRATION 1763 0.0132
493 GROIN PAIN 116 0.0132
494 EATING DISORDER 281 0.0132
495 MUSCULOSKELETAL DISCOMFORT 227 0.0132
496 THROMBOSIS 1058 0.0131
497 ACCIDENT 157 0.0131
498 CYST 163 0.0131
499 DRUG INTERACTION 2081 0.0131
500 SKIN INFECTION 147 0.0131
501 MENTAL IMPAIRMENT 316 0.0130
502 DISTURBANCE IN ATTENTION 700 0.0130
503 PULMONARY OEDEMA 581 0.0130
504 HYPOMAGNESAEMIA 180 0.0129
505 OXYGEN SATURATION DECREASED 726 0.0129
506 MASS 180 0.0129
507 ASPHYXIA 105 0.0128
508 HYPERKALAEMIA 451 0.0128
509 PRODUCT USE IN UNAPPROVED INDICATION 3179 0.0128
510 NEOPLASM PROGRESSION 446 0.0128
511 HYPERLIPIDAEMIA 153 0.0128
512 DEVICE RELATED INFECTION 197 0.0128
513 HERPES ZOSTER 734 0.0128
514 NEPHROLITHIASIS 584 0.0127
515 MUSCULOSKELETAL DISORDER 242 0.0127
516 HAEMORRHOIDS 247 0.0126
517 NEPHROPATHY 118 0.0126
518 METASTASES TO LUNG 146 0.0126
519 ASPARTATE AMINOTRANSFERASE INCREASED 671 0.0126
520 HYPOALBUMINAEMIA 98 0.0126
521 PHOTOSENSITIVITY REACTION 208 0.0126
522 SEASONAL ALLERGY 178 0.0126
523 DYSARTHRIA 470 0.0125
524 BREAST CANCER METASTATIC 134 0.0125
525 PRODUCT ADHESION ISSUE 444 0.0124
526 PAIN IN JAW 352 0.0124
527 STENT PLACEMENT 100 0.0124
528 UPPER LIMB FRACTURE 247 0.0124
529 MALAISE 5436 0.0124
530 ELECTROLYTE IMBALANCE 144 0.0124
531 THROMBOCYTOPENIA 1386 0.0124
532 PRODUCT PHYSICAL ISSUE 250 0.0124
533 BRONCHITIS 917 0.0124
534 GALLBLADDER DISORDER 221 0.0124
535 HALLUCINATION 933 0.0124
536 ORAL CANDIDIASIS 163 0.0124
537 CARPAL TUNNEL SYNDROME 173 0.0123
538 HEPATIC CYTOLYSIS 157 0.0123
539 PLEURAL EFFUSION 749 0.0123
540 PROSTATIC SPECIFIC ANTIGEN INCREASED 169 0.0123
541 HAEMOGLOBIN DECREASED 1259 0.0122
542 RESPIRATORY FAILURE 894 0.0122
543 WHITE BLOOD CELL COUNT INCREASED 470 0.0122
544 HEPATIC ENCEPHALOPATHY 114 0.0122
545 INTESTINAL OBSTRUCTION 460 0.0122
546 BODY TEMPERATURE DECREASED 120 0.0122
547 BLOOD SODIUM DECREASED 229 0.0121
548 LABORATORY TEST ABNORMAL 358 0.0121
549 HIP FRACTURE 390 0.0121
550 INFUSION SITE PAIN 156 0.0121
551 INFUSION SITE ERYTHEMA 102 0.0121
552 GOUT 217 0.0121
553 HEADACHE 7576 0.0121
554 HALLUCINATION, VISUAL 255 0.0121
555 WHITE BLOOD CELL COUNT DECREASED 1309 0.0121
556 LOSS OF CONSCIOUSNESS 1547 0.0121
557 PANCYTOPENIA 673 0.0120
558 ELECTROCARDIOGRAM QT PROLONGED 433 0.0120
559 KIDNEY INFECTION 236 0.0120
560 CYTOKINE RELEASE SYNDROME 241 0.0120
561 TACHYCARDIA 1066 0.0120
562 SKIN LESION 329 0.0120
563 INTENTIONAL OVERDOSE 769 0.0120
564 DISEASE PROGRESSION 1414 0.0119
565 PERSONALITY CHANGE 111 0.0119
566 COLITIS 452 0.0119
567 CHOLECYSTITIS 142 0.0119
568 HEPATIC STEATOSIS 222 0.0119
569 HAIR TEXTURE ABNORMAL 159 0.0119
570 PANIC ATTACK 433 0.0119
571 LYMPHOCYTE COUNT DECREASED 210 0.0119
572 HYPONATRAEMIA 668 0.0118
573 PRODUCT QUALITY ISSUE 1606 0.0118
574 COGNITIVE DISORDER 552 0.0118
575 HEAD INJURY 374 0.0118
576 DISORIENTATION 468 0.0118
577 MADAROSIS 137 0.0118
578 HAEMATOCRIT DECREASED 234 0.0118
579 ALANINE AMINOTRANSFERASE INCREASED 723 0.0118
580 DYSPNOEA EXERTIONAL 443 0.0117
581 URINARY TRACT INFECTION 1996 0.0117
582 PANCREATITIS 613 0.0116
583 OBSTRUCTIVE AIRWAYS DISORDER 129 0.0116
584 STAPHYLOCOCCAL INFECTION 382 0.0116
585 ILLNESS 1193 0.0116
586 ESCHERICHIA INFECTION 95 0.0115
587 OESOPHAGITIS 126 0.0115
588 RASH PRURITIC 623 0.0115
589 DECREASED ACTIVITY 124 0.0115
590 VITAMIN D DEFICIENCY 112 0.0115
591 EMBOLISM 95 0.0114
592 ABSCESS 182 0.0114
593 DYSURIA 419 0.0114
594 THINKING ABNORMAL 212 0.0114
595 SURGERY 667 0.0114
596 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 592 0.0113
597 DRUG ERUPTION 201 0.0113
598 COLITIS ULCERATIVE 506 0.0113
599 MYDRIASIS 144 0.0112
600 HERNIA 217 0.0112
601 LACERATION 105 0.0112
602 COAGULOPATHY 186 0.0112
603 RETCHING 238 0.0112
604 BLOOD BILIRUBIN INCREASED 301 0.0111
605 DIZZINESS 5556 0.0111
606 TUMOUR LYSIS SYNDROME 98 0.0111
607 SKIN LACERATION 121 0.0111
608 BLOOD IRON DECREASED 132 0.0111
609 TINNITUS 510 0.0111
610 SCAR 190 0.0111
611 SECOND PRIMARY MALIGNANCY 92 0.0110
612 UPPER GASTROINTESTINAL HAEMORRHAGE 186 0.0110
613 PULMONARY HYPERTENSION 230 0.0110
614 PARANOIA 190 0.0110
615 DEFORMITY 103 0.0110
616 MUSCLE STRAIN 95 0.0110
617 BLOOD COUNT ABNORMAL 166 0.0109
618 NEUTROPHIL COUNT DECREASED 446 0.0109
619 FRACTURE 207 0.0109
620 RHABDOMYOLYSIS 455 0.0109
621 BLOOD POTASSIUM INCREASED 177 0.0109
622 DYSSTASIA 318 0.0109
623 NOCTURIA 132 0.0109
624 MUSCLE RIGIDITY 130 0.0109
625 PROCEDURAL PAIN 301 0.0108
626 BLOOD CREATININE INCREASED 707 0.0108
627 PLATELET COUNT DECREASED 1154 0.0108
628 HYPOTENSION 2170 0.0108
629 SWOLLEN TONGUE 337 0.0108
630 MITRAL VALVE INCOMPETENCE 122 0.0108
631 URINARY INCONTINENCE 319 0.0108
632 INTERNAL HAEMORRHAGE 123 0.0108
633 MUCOSAL INFLAMMATION 281 0.0107
634 PRODUCT PRESCRIBING ERROR 254 0.0107
635 DISSEMINATED INTRAVASCULAR COAGULATION 150 0.0106
636 NODULE 139 0.0106
637 ORAL DISCOMFORT 148 0.0106
638 PERICARDIAL EFFUSION 246 0.0106
639 SUICIDE ATTEMPT 645 0.0106
640 GASTROINTESTINAL PAIN 117 0.0106
641 MUSCLE TWITCHING 245 0.0106
642 PNEUMONITIS 289 0.0106
643 ANAEMIA 2024 0.0106
644 BLOOD ALKALINE PHOSPHATASE INCREASED 263 0.0106
645 POOR VENOUS ACCESS 109 0.0105
646 FLUID OVERLOAD 153 0.0105
647 IMMUNE SYSTEM DISORDER 138 0.0105
648 HYPOTHYROIDISM 334 0.0104
649 ORTHOSTATIC HYPOTENSION 182 0.0104
650 BLOOD URINE PRESENT 198 0.0104
651 LUNG INFECTION 162 0.0104
652 HEART RATE DECREASED 366 0.0104
653 MOOD SWINGS 331 0.0104
654 RESPIRATORY DISTRESS 286 0.0104
655 POOR QUALITY SLEEP 223 0.0103
656 OFF LABEL USE 9051 0.0103
657 FISTULA 116 0.0103
658 DIZZINESS POSTURAL 100 0.0103
659 LIMB DISCOMFORT 319 0.0103
660 FEELING HOT 632 0.0103
661 GASTRIC DISORDER 353 0.0103
662 CYSTITIS 327 0.0103
663 SUICIDAL IDEATION 939 0.0102
664 FEELING ABNORMAL 2454 0.0102
665 GASTROENTERITIS VIRAL 184 0.0102
666 HEPATOMEGALY 100 0.0102
667 DYSPHAGIA 965 0.0102
668 TACHYPNOEA 138 0.0101
669 GASTRITIS 267 0.0101
670 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 236 0.0101
671 INCREASED TENDENCY TO BRUISE 93 0.0101
672 CRYING 367 0.0101
673 HYPOCALCAEMIA 191 0.0101
674 METASTASES TO CENTRAL NERVOUS SYSTEM 130 0.0101
675 PERIPHERAL COLDNESS 138 0.0100
676 POST PROCEDURAL COMPLICATION 192 0.0100
677 RENAL DISORDER 465 0.0100
678 CHOLECYSTECTOMY 114 0.0100
679 RESTLESSNESS 365 0.0100
680 APPENDICITIS 93 0.0099
681 FUNGAL INFECTION 331 0.0099
682 TRANSFUSION 104 0.0099
683 HEPATIC FAILURE 299 0.0099
684 TREMOR 1646 0.0099
685 SCAB 113 0.0099
686 OSTEONECROSIS OF JAW 245 0.0099
687 PRODUCTIVE COUGH 472 0.0099
688 CARDIOMYOPATHY 146 0.0099
689 ANGER 334 0.0099
690 COLD SWEAT 174 0.0099
691 INTERSTITIAL LUNG DISEASE 477 0.0098
692 BALANCE DISORDER 849 0.0098
693 NEUROTOXICITY 172 0.0098
694 SPUTUM DISCOLOURED 93 0.0098
695 SENSORY DISTURBANCE 157 0.0098
696 MULTIPLE ORGAN DYSFUNCTION SYNDROME 277 0.0098
697 UNDERDOSE 712 0.0097
698 AGITATION 716 0.0097
699 LYMPHADENOPATHY 341 0.0096
700 MUSCLE ATROPHY 122 0.0096
701 CHROMATURIA 217 0.0096
702 ALTERED STATE OF CONSCIOUSNESS 208 0.0096
703 TOOTH EXTRACTION 119 0.0096
704 RESPIRATORY TRACT INFECTION 249 0.0096
705 DERMATITIS CONTACT 109 0.0095
706 DRUG LEVEL INCREASED 158 0.0095
707 GASTRIC ULCER 181 0.0095
708 FEELING COLD 265 0.0095
709 HAEMATEMESIS 241 0.0095
710 THERAPEUTIC RESPONSE DECREASED 576 0.0095
711 HAEMATOCHEZIA 524 0.0095
712 THYROID DISORDER 146 0.0095
713 VISUAL IMPAIRMENT 1173 0.0095
714 DELUSION 147 0.0095
715 GENERALISED OEDEMA 117 0.0094
716 DYSPHONIA 551 0.0094
717 DYSGEUSIA 698 0.0094
718 CYTOPENIA 115 0.0094
719 BRAIN FOG 147 0.0094
720 FEELING JITTERY 178 0.0093
721 SINUS CONGESTION 126 0.0093
722 PHOTOPHOBIA 175 0.0093
723 ACUTE HEPATIC FAILURE 127 0.0093
724 HOSPITALISATION 1426 0.0093
725 EAR DISCOMFORT 95 0.0092
726 CHILLS 1085 0.0092
727 DRUG INEFFECTIVE 12175 0.0092
728 FLATULENCE 523 0.0092
729 HAEMOPTYSIS 257 0.0092
730 PHARYNGITIS 114 0.0092
731 RESPIRATORY TRACT CONGESTION 146 0.0092
732 SPEECH DISORDER 481 0.0092
733 INTESTINAL PERFORATION 103 0.0092
734 LOCAL SWELLING 160 0.0092
735 HOT FLUSH 691 0.0092
736 CYANOSIS 144 0.0091
737 BLOOD PRESSURE INCREASED 1399 0.0091
738 EPISTAXIS 682 0.0091
739 BLOOD TEST ABNORMAL 128 0.0091
740 ATAXIA 108 0.0091
741 SEPTIC SHOCK 394 0.0090
742 PHARYNGITIS STREPTOCOCCAL 98 0.0090
743 SINUS DISORDER 179 0.0090
744 OROPHARYNGEAL PAIN 836 0.0090
745 RENAL IMPAIRMENT 757 0.0090
746 HALLUCINATION, AUDITORY 143 0.0090
747 AGEUSIA 224 0.0090
748 DYSKINESIA 364 0.0089
749 HAEMATOMA 232 0.0089
750 LEUKOPENIA 447 0.0089
751 HYPERGLYCAEMIA 324 0.0089
752 PELVIC PAIN 161 0.0089
753 CHOLELITHIASIS 290 0.0088
754 NEPHROPATHY TOXIC 99 0.0088
755 APHASIA 266 0.0088
756 GASTROINTESTINAL HAEMORRHAGE 735 0.0088
757 CARDIAC DISORDER 820 0.0088
758 POST PROCEDURAL HAEMORRHAGE 102 0.0088
759 BURNING SENSATION 614 0.0087
760 MOUTH ULCERATION 184 0.0087
761 HAEMATURIA 298 0.0087
762 MICTURITION URGENCY 99 0.0087
763 SKIN FISSURES 169 0.0086
764 PRODUCT TASTE ABNORMAL 117 0.0086
765 DRUG PRESCRIBING ERROR 166 0.0086
766 VERTIGO 526 0.0086
767 MYOCARDIAL ISCHAEMIA 98 0.0086
768 PSORIASIS 1122 0.0086
769 DIPLOPIA 223 0.0086
770 ABNORMAL BEHAVIOUR 338 0.0085
771 PARALYSIS 122 0.0085
772 BRADYCARDIA 452 0.0085
773 PLATELET COUNT INCREASED 111 0.0085
774 SEIZURE 982 0.0085
775 AGGRESSION 424 0.0085
776 INCORRECT PRODUCT ADMINISTRATION DURATION 183 0.0084
777 SEXUAL DYSFUNCTION 99 0.0084
778 SKIN DISCOLOURATION 388 0.0084
779 INSURANCE ISSUE 129 0.0084
780 EJECTION FRACTION DECREASED 131 0.0084
781 BLOOD PRESSURE DECREASED 558 0.0084
782 SKIN DISORDER 280 0.0084
783 BLOOD PRESSURE ABNORMAL 166 0.0083
784 WRONG TECHNIQUE IN DRUG USAGE PROCESS 303 0.0083
785 MUSCLE TIGHTNESS 135 0.0083
786 ACTIVITIES OF DAILY LIVING IMPAIRED 165 0.0083
787 COLON CANCER 124 0.0083
788 IRRITABILITY 500 0.0083
789 INJECTION SITE REACTION 571 0.0083
790 CENTRAL NERVOUS SYSTEM LESION 114 0.0083
791 ATRIAL FIBRILLATION 805 0.0083
792 DRUG EFFECT DECREASED 444 0.0082
793 POLLAKIURIA 343 0.0082
794 INFLUENZA 916 0.0082
795 HYPOKINESIA 119 0.0082
796 CHOLESTASIS 156 0.0081
797 SUBDURAL HAEMATOMA 116 0.0081
798 RASH MACULO-PAPULAR 180 0.0081
799 PRESYNCOPE 196 0.0081
800 EYE INFECTION 91 0.0081
801 ABDOMINAL PAIN LOWER 203 0.0080
802 VENTRICULAR TACHYCARDIA 131 0.0079
803 INTENTIONAL SELF-INJURY 160 0.0079
804 NEUTROPENIA 1060 0.0078
805 DEPRESSED MOOD 412 0.0078
806 INTERNATIONAL NORMALISED RATIO INCREASED 222 0.0078
807 BACTERIAL INFECTION 145 0.0078
808 HEPATOTOXICITY 173 0.0078
809 RHINORRHOEA 502 0.0078
810 BLOOD UREA INCREASED 130 0.0078
811 FAECES DISCOLOURED 167 0.0077
812 PRODUCT SUBSTITUTION ISSUE 443 0.0077
813 ORAL HERPES 150 0.0077
814 ABNORMAL DREAMS 212 0.0077
815 RASH ERYTHEMATOUS 367 0.0077
816 MULTIPLE FRACTURES 126 0.0077
817 LIVER FUNCTION TEST ABNORMAL 223 0.0077
818 HEAD DISCOMFORT 135 0.0076
819 SHOCK 175 0.0076
820 SYNCOPE 761 0.0076
821 ACUTE MYOCARDIAL INFARCTION 223 0.0076
822 HEART RATE INCREASED 746 0.0075
823 DRUG EFFECT INCOMPLETE 272 0.0075
824 CORONARY ARTERY DISEASE 226 0.0075
825 EMOTIONAL DISORDER 230 0.0075
826 TREATMENT NONCOMPLIANCE 406 0.0074
827 THERAPY INTERRUPTED 530 0.0074
828 MYALGIA 1259 0.0074
829 PRODUCT DOSE OMISSION 482 0.0074
830 THERAPEUTIC RESPONSE UNEXPECTED 331 0.0074
831 TRANSIENT ISCHAEMIC ATTACK 248 0.0073
832 MALIGNANT MELANOMA 98 0.0073
833 HYPOAESTHESIA ORAL 110 0.0073
834 LACRIMATION INCREASED 220 0.0073
835 APATHY 106 0.0073
836 PALPITATIONS 851 0.0073
837 GASTROENTERITIS 106 0.0073
838 PSYCHOMOTOR HYPERACTIVITY 120 0.0072
839 CHOKING 141 0.0072
840 INFLUENZA LIKE ILLNESS 594 0.0072
841 NERVOUSNESS 377 0.0072
842 HEART RATE IRREGULAR 163 0.0072
843 INTENTIONAL DOSE OMISSION 204 0.0071
844 BONE DENSITY DECREASED 224 0.0071
845 GENERALISED TONIC-CLONIC SEIZURE 118 0.0071
846 ECZEMA 372 0.0071
847 VISION BLURRED 975 0.0071
848 ABASIA 175 0.0071
849 NASAL CONGESTION 415 0.0071
850 COUGH 1979 0.0070
851 APHONIA 98 0.0070
852 COORDINATION ABNORMAL 97 0.0069
853 MOVEMENT DISORDER 223 0.0069
854 BLOOD LACTATE DEHYDROGENASE INCREASED 110 0.0069
855 CARDIAC FAILURE CONGESTIVE 557 0.0069
856 THERAPY CESSATION 355 0.0069
857 ISCHAEMIC STROKE 123 0.0069
858 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 378 0.0069
859 HEPATIC FUNCTION ABNORMAL 257 0.0069
860 FEMUR FRACTURE 213 0.0069
861 EYE PAIN 388 0.0069
862 PSYCHOTIC DISORDER 203 0.0069
863 MOOD ALTERED 187 0.0068
864 FEAR 183 0.0068
865 LYMPHOMA 105 0.0068
866 THIRST 121 0.0068
867 DEAFNESS 177 0.0068
868 ACUTE MYELOID LEUKAEMIA 105 0.0067
869 PANCREATITIS ACUTE 151 0.0067
870 DIABETES MELLITUS 511 0.0067
871 ANAPHYLACTIC REACTION 369 0.0067
872 THROAT IRRITATION 299 0.0067
873 HYPOGLYCAEMIA 322 0.0066
874 CHEST DISCOMFORT 679 0.0066
875 PRODUCT DOSE OMISSION IN ERROR 187 0.0066
876 THERAPY PARTIAL RESPONDER 103 0.0066
877 PRODUCT USE COMPLAINT 104 0.0066
878 PALLOR 179 0.0066
879 GAMMA-GLUTAMYLTRANSFERASE INCREASED 145 0.0065
880 ERYTHEMA 1342 0.0065
881 CEREBROVASCULAR ACCIDENT 1105 0.0065
882 HEMIPARESIS 110 0.0065
883 PULMONARY ARTERIAL HYPERTENSION 94 0.0065
884 COVID-19 1137 0.0065
885 NERVOUS SYSTEM DISORDER 202 0.0065
886 NEOPLASM MALIGNANT 431 0.0065
887 RENAL FAILURE ACUTE 274 0.0065
888 MIDDLE INSOMNIA 120 0.0064
889 PARAESTHESIA ORAL 92 0.0064
890 PRURITUS GENERALISED 137 0.0063
891 ERECTILE DYSFUNCTION 162 0.0063
892 CONJUNCTIVITIS 117 0.0063
893 BONE LOSS 94 0.0062
894 JAUNDICE 168 0.0062
895 PRODUCT AVAILABILITY ISSUE 142 0.0062
896 SWELLING FACE 406 0.0062
897 GLAUCOMA 120 0.0062
898 DRUG DOSE OMISSION 1021 0.0062
899 PRODUCT DOSE OMISSION ISSUE 1813 0.0062
900 CATARACT 366 0.0061
901 HYPOACUSIS 264 0.0061
902 TRANSAMINASES INCREASED 136 0.0061
903 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1102 0.0061
904 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 433 0.0061
905 VIRAL INFECTION 199 0.0060
906 RASH MACULAR 209 0.0060
907 AGRANULOCYTOSIS 111 0.0060
908 BLINDNESS 243 0.0060
909 DRY EYE 296 0.0059
910 SNEEZING 133 0.0059
911 MELAENA 130 0.0059
912 ERUCTATION 114 0.0059
913 PRODUCT ADMINISTRATION ERROR 119 0.0059
914 CIRCULATORY COLLAPSE 100 0.0059
915 DEMENTIA 164 0.0059
916 OSTEONECROSIS 191 0.0058
917 MYOCARDIAL INFARCTION 1014 0.0058
918 BONE MARROW FAILURE 118 0.0058
919 DIABETES MELLITUS INADEQUATE CONTROL 102 0.0058
920 LUNG NEOPLASM MALIGNANT 234 0.0057
921 DERMATITIS 118 0.0056
922 EYE DISORDER 184 0.0056
923 DRY SKIN 742 0.0056
924 SKIN CANCER 119 0.0055
925 PROTEINURIA 104 0.0055
926 DYSTONIA 106 0.0055
927 SKIN EXFOLIATION 454 0.0054
928 LIP SWELLING 178 0.0053
929 THROAT TIGHTNESS 144 0.0053
930 BLOOD TRIGLYCERIDES INCREASED 93 0.0053
931 EYE SWELLING 194 0.0052
932 ANGINA PECTORIS 149 0.0052
933 FLUSHING 524 0.0051
934 CARDIAC FAILURE 413 0.0051
935 BLOOD CREATINE PHOSPHOKINASE INCREASED 148 0.0051
936 PANCREATIC CARCINOMA 148 0.0051
937 LACTIC ACIDOSIS 165 0.0051
938 STEVENS-JOHNSON SYNDROME 113 0.0051
939 ARRHYTHMIA 239 0.0050
940 HAEMORRHAGE 519 0.0050
941 CEREBRAL INFARCTION 121 0.0049
942 MULTIPLE SCLEROSIS RELAPSE 335 0.0049
943 RASH GENERALISED 126 0.0049
944 PRODUCT DISPENSING ERROR 103 0.0047
945 APPLICATION SITE PAIN 102 0.0046
946 PERITONITIS 95 0.0046
947 CEREBRAL HAEMORRHAGE 164 0.0046
948 MULTIPLE SCLEROSIS 218 0.0046
949 APPLICATION SITE PRURITUS 103 0.0045
950 OCULAR HYPERAEMIA 215 0.0045
951 THERAPEUTIC RESPONSE SHORTENED 150 0.0045
952 PREMATURE BABY 136 0.0045
953 RASH PAPULAR 101 0.0045
954 DIABETIC KETOACIDOSIS 108 0.0045
955 APPLICATION SITE ERYTHEMA 115 0.0044
956 BLOOD GLUCOSE DECREASED 206 0.0043
957 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 858 0.0042
958 INCORRECT DRUG ADMINISTRATION DURATION 119 0.0042
959 VAGINAL HAEMORRHAGE 178 0.0041
960 EXPIRED PRODUCT ADMINISTERED 129 0.0039
961 VISUAL ACUITY REDUCED 127 0.0038
962 EYE IRRITATION 219 0.0038
963 INJECTION SITE BRUISING 288 0.0036
964 DISEASE RECURRENCE 170 0.0036
965 ANAPHYLACTIC SHOCK 92 0.0036
966 EXTRA DOSE ADMINISTERED 143 0.0035
967 PAIN OF SKIN 95 0.0035
968 DRUG ADMINISTRATION ERROR 108 0.0035
969 BLOOD GLUCOSE INCREASED 661 0.0035
970 CONVULSION 197 0.0034
971 INCORRECT DOSE ADMINISTERED 782 0.0034
972 EYE PRURITUS 108 0.0032
973 INJECTION SITE PRURITUS 209 0.0031
974 ACNE 233 0.0031
975 DEVICE ISSUE 269 0.0030
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 104 0.0029
977 DEVICE MALFUNCTION 203 0.0029
978 INJECTION SITE PAIN 862 0.0028
979 DEVICE DISLOCATION 122 0.0028
980 ANGIOEDEMA 117 0.0026
981 SKIN IRRITATION 112 0.0024
982 INJECTION SITE HAEMORRHAGE 189 0.0024
983 INJECTION SITE ERYTHEMA 283 0.0023
984 BREAST CANCER 200 0.0021
985 NO ADVERSE EVENT 388 0.0021
986 ACCIDENTAL EXPOSURE TO PRODUCT 220 0.0021
987 SKIN BURNING SENSATION 150 0.0021
988 INJECTION SITE SWELLING 154 0.0020
989 DERMATITIS ATOPIC 104 0.0020
990 PROSTATE CANCER 139 0.0017
991 PRODUCT STORAGE ERROR 95 0.0011